YaoGeJu

← Back to list

Tafluprost Eye Drops

Matched
Active ingredients (original)
TAFLUPROST
Dosage form (original)
SOLUTION/DROPS
Route (original)
OPHTHALMIC

Read these limits

  1. US patent expiration does not establish Chinese patent expiration. Dates here come from the US Orange Book; Chinese patent status needs separate checking.
  2. The Orange Book lists holder-submitted patents and does not cover all related patents.
  3. “Unmatched” means no English ingredient-name counterpart in the Chinese official-name sources loaded here; it does not mean no Chinese approval or filing. A zero count means a Chinese name is matched but no records were found in the loaded source. Source dates appear below.
  4. This page contains no sales or market-size data and cannot establish development value.
  5. Names on unmatched rows are the original FDA Orange Book names, without Chinese translation. The same ingredient may have a different generic name in China.

US-approved products

Application numbers, product numbers and original fields are retained. Marketing status is shown as listed in the source.

Earliest approval2012/02/10
ANDA applications3
RLD applicantTHEA PHARMA INC

Currently marketed products: 4 · Counts FDA prescription and OTC marketing categories as listed; discontinued or unknown categories are excluded.

Application / product numberBrand name (original)Applicant (original)Dosage form (original)Route (original)Strength (original)Earliest approvalRLD / RSMarketing status (original)Official source
A209040-001TAFLUPROSTSANDOZ INCSOLUTION/DROPSOPHTHALMICTAFLUPROST: 0.0015%2022/01/28N / NHUMAN PRESCRIPTION DRUGopenFDA ↗
A209051-001TAFLUPROSTMICRO LABS LTDSOLUTION/DROPSOPHTHALMICTAFLUPROST: 0.0015%2019/08/19N / NHUMAN PRESCRIPTION DRUGopenFDA ↗
A218002-001TAFLUPROSTINGENUS PHARMACEUTICALS LLCSOLUTION/DROPSOPHTHALMICTAFLUPROST: 0.0015%2024/04/05N / NHUMAN PRESCRIPTION DRUGopenFDA ↗
N202514-001ZIOPTANTHEA PHARMA INCSOLUTION/DROPSOPHTHALMICTAFLUPROST: 0.0015%2012/02/10Y / YHUMAN PRESCRIPTION DRUGopenFDA ↗

Listed US patents

*PED rows, substance/product flags, use codes and delisting-request flags are retained without determining legal effect.

Latest listed patent expiration2029/05/28
Substance patent expiration (DS flag)—

This column includes only source rows explicitly flagged DS. A PED row without that flag is not assigned one by this site.

Application / product numberPatent numberListed expirationSubstance / product flagsUse codeDelisting requestOfficial source
N202514-001108641592029/05/28— / YU-778—openFDA ↗
N202514-00199995932029/05/28— / Y——openFDA ↗

Exclusivity source records

FDA exclusivity code list ↗

Latest exclusivity expiration: —

Application / product numberExclusivity codeListed expirationOfficial source
Not listed

Chinese record details

Chinese product landscape ↗

The four-zero filter applies only to matched rows: catalog holders, NHSA approval numbers, applications under review, and companies filing generics this year. Unmatched rows have no Chinese counts. Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.

Catalog holders 1

Company (original)Identifier (original)Source dateOfficial source
Santen Pharmaceutical Co.,Ltd.H201504230.0015%(2.5ml:37.5μg)2015/07/27Official source ↗

NHSA approval numbers 13

Company (original)Identifier (original)Source dateOfficial source
Shenyang Xing Qi Yan Yao Co., Ltd. romanized国药准字H202531640.0015%(0.3ml:4.5μg)—Official source ↗
Yangtze River Pharmaceutical Group Co., Ltd国药准字H202436900.0015%(0.3ml:4.5μg)—Official source ↗
Hangzhou Minsheng Pharmaceutical Co., Ltd国药准字H202448550.0015%(2.5ml∶37.5μg)—Official source ↗
Zhejiang Jian Feng Pharma Co., Ltd. romanized国药准字H202435900.0015%(2.5ml: 37.5μg)—Official source ↗
Hainan Si Da Pharmaceutical Co., Ltd. romanized国药准字H202560770.0015%(0.3ml:4.5μg)—Official source ↗
Santen Pharmaceutical Co., Ltd.国药准字J201501310.0015%(2.5ml:37.5μg)—Official source ↗
Santen Pharmaceutical Co.,Ltd.国药准字HJ201910240.0015%(0.3ml:4.5μg)—Official source ↗
Chengdu Sheng Di Pharmaceuticals Co., Ltd. romanized国药准字H202138550.0015%(0.3ml:4.5μg)—Official source ↗
Shaanxi Li Cai Pharma Co., Ltd. romanized国药准字H202449140.0015%(0.3ml:4.5μg)—Official source ↗
Suzhou Ou Kang Wei Shi Bio Technology Co., Ltd. romanized国药准字H202533590.0015%(0.3ml:4.5µg)—Official source ↗
Jiangsu An Bi Sheng Pharmaceutical Co., Ltd. romanized国药准字H202545640.0015%(0.3ml:4.5μg)—Official source ↗
Hubei Min Kang Pharma Group Co., Ltd. romanized国药准字H202560670.0015%(0.3ml:4.5μg)—Official source ↗
Hainan Si Da Pharmaceutical Co., Ltd. romanized国药准字H202560770.0015%(0.3ml:4.5μg)—Official source ↗
Santen Pharmaceutical Co.,Ltd.国药准字HJ201910240.0015%(0.3ml:4.5μg)—Official source ↗
Chengdu Sheng Di Pharmaceuticals Co., Ltd. romanized国药准字H202138550.0015%(0.3ml:4.5μg)—Official source ↗
Chengdu Sheng Di Pharmaceuticals Co., Ltd. romanized国药准字H202138550.0015%(0.3ml:4.5μg)—Official source ↗
Santen Pharmaceutical Co.,Ltd.国药准字HJ201505280.0015%(2.5ml:37.5μg)—Official source ↗

Under review 3

Company (original)Identifier (original)Source dateOfficial source
Shandong Chen Xin Fu Dou Pharma Co., Ltd. romanizedCYHS25038572025/11/03Official source ↗
Hong Yue Technology (Hu Zhou) Co., Ltd. romanized; Hangzhou Minsheng Pharmaceutical Co., LtdCYHS26027972026/11/12Official source ↗
Chongqing Ke Rui Pharmaceutical (Group) Co., Ltd. romanizedCYHS26027962026/11/12Official source ↗

Generic-filing companies this year 2

Company (original)Identifier (original)Source dateOfficial source
Hong Yue Technology (Hu Zhou) Co., Ltd. romanized; Hangzhou Minsheng Pharmaceutical Co., LtdCYHS26027972026/11/12Official source ↗
Chongqing Ke Rui Pharmaceutical (Group) Co., Ltd. romanizedCYHS26027962026/11/12Official source ↗

API companies with A status 5

Company (original)Identifier (original)Source dateOfficial source
Zhejiang Ao Xiang Pharma Co., Ltd. romanizedY202200007472026/09/24Official source ↗
Jia He Gui Technology Co., Ltd. You Shi Factory romanizedY202100003952024/02/08Official source ↗
Yang Zi Jiang Pharma Group Jiangsu Hai Ci Bio Pharma Co., Ltd. romanizedY202100003672023/06/12Official source ↗
Zhejiang Jian Feng Pharma Co., Ltd. romanizedY202100000932023/08/16Official source ↗
Zhejiang Tian Yu Pharma Co., Ltd. romanizedY201900005072026/08/15Official source ↗

Trial registrations 2025/2026 —

Not loaded

Sources and dates

FDA Orange Book
2026/11/06
CDE acceptance and review
2026/11/16 06:38
Chemical Drug Catalog
2026/11/16 06:35
API registration records
2026/11/16 06:37
NHSA drug code database
2026/10/23
Trial registry
2026/11/16 08:10 · Incomplete coverage

Chinese counts use complete ingredient, dosage-form and route matches. Unmatched and partial rows show name-source matching only and make no finding about Chinese approvals or filings. Trials cover registration-number years 2025/2026 only.

Comparison generated: 2026/11/16 08:41 · openFDA Orange Book ↗

Name and dosage-form matching sources